NaviGate Cardiac Structures, Inc. (“NCSI”) reports first heterotopic transcatheter GATE™ tricuspid valved stent successful implantation


Apr 26, 2017   •  Press Release

LAKE FOREST, Calif., Apr, 26, 2017 - NaviGate Cardiac Structures Inc. (“NCSI”) announced today that the GATE™ catheter-guided tricuspid atrioventricular valved stent (AVS) was implanted through the jugular vein one week ago in a patient suffering from severe tricuspid regurgitation stemming from two failed tricuspid annuloplasty rings that were unable to maintain the patient’s valve competence. The patient, a 78-year-old man with a long history of cardiac conditions, has undergone…

Continue Reading